6-52509577-A-C
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_012288.4(TRAM2):c.421T>G(p.Leu141Val) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a benign outcome for this variant. 12/20 in silico tools predict a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Consequence
NM_012288.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
TRAM2 | NM_012288.4 | c.421T>G | p.Leu141Val | missense_variant | 5/11 | ENST00000182527.4 | NP_036420.1 | |
TRAM2 | XM_011515005.3 | c.310T>G | p.Leu104Val | missense_variant | 4/10 | XP_011513307.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
TRAM2 | ENST00000182527.4 | c.421T>G | p.Leu141Val | missense_variant | 5/11 | 1 | NM_012288.4 | ENSP00000182527.3 | ||
EFHC1 | ENST00000637353.1 | c.1852-13307A>C | intron_variant | 5 | ENSP00000490441.1 | |||||
EFHC1 | ENST00000636343.1 | c.1516-6318A>C | intron_variant | 5 | ENSP00000490193.1 | |||||
EFHC1 | ENST00000637602.1 | n.*1553-13307A>C | intron_variant | 2 | ENSP00000490074.1 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome Cov.: 31
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Oct 01, 2024 | The c.421T>G (p.L141V) alteration is located in exon 5 (coding exon 5) of the TRAM2 gene. This alteration results from a T to G substitution at nucleotide position 421, causing the leucine (L) at amino acid position 141 to be replaced by a valine (V). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
No publications associated with this variant yet.